Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
تحليل معلومات السوق
مدعوم بالذكاء الاصطناعيCybin Inc. will transfer its U.S. stock exchange listing from NYSE American to the Nasdaq Global Market, with trading expected to cease on NYSE American at market close.
Market impact analysis based on neutral sentiment with 80% confidence.
سياق المقال
TORONTO, December 18, 2025--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market ("Nasdaq") from the NYSE American LLC ("NYSE American"). The Company expects that its common shares will cease trading on the NYSE American at market clos
التحليل والرؤى المقدمة من AnalystMarkets AI.